US2011020789A1PendingUtilityA1
Methods for assessing fatigue level and applications thereof
Assignee: VIRUS IKAGAKU KENKYUSHO INCPriority: Jul 14, 2004Filed: Sep 15, 2010Published: Jan 27, 2011
Est. expiryJul 14, 2024(expired)· nominal 20-yr term from priority
Inventors:Kazuhiro Kondo
C12Q 1/705A61B 5/14546A61B 5/16A61B 5/165A61B 5/417C12Q 1/6883G01N 33/56994G01N 2800/306C12Q 2600/158
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Level of fatigue that accompanies everyday life or a disease can be simply, easily, and quantitatively assessed by obtaining a body fluid from a test subject and measuring the amount of human herpesvirus in the body fluid. Furthermore, the anti-fatigue potency of anti-fatigue substances and anti-fatigue food products can be measured.
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
15 . A method of assessing if a test subject is in a state of physiological fatigue comprising:
(a) preparing a saliva sample from a test subject; (b) measuring the amount of human herpesvirus 6 or 7 viruses in the saliva sample by measuring the amount of human herpesvirus 6 or 7 protein present in the sample; and (c) determining if the amount of either human herpesvirus 6 or 7 in the saliva sample is higher than the average amount detected in healthy persons whose physical and mental work capability is not deteriorated,
wherein a higher than average amount of either human herpesvirus 6 or 7 in saliva signifies that the test subject is experiencing a reactivated human herpesvirus 6 or 7 viral infection and
wherein the higher than average amount of either human herpesvirus 6 or 7 in saliva is a positive indication of physiological fatigue.
16 . The method of claim 15 , wherein the physiological fatigue is due to an accumulation of physiological fatigue arising from everyday life.
17 . The method of claim 15 , wherein the amount of human herpesvirus 6 or 7 protein present in the sample is measured by an immunoassay method.
18 . A method of assessing if a test subject is in a state of physiological fatigue comprising:
(a) preparing saliva samples from healthy adults immediately after resting period; (b) preparing a saliva sample from the test subject at an arbitrary time point; (c) measuring the amount of human herpesvirus 6 or 7 in the samples obtained in (a) and (b) by measuring the amount of human herpesvirus 6 or 7 protein present in the samples; and (d) assessing that the test subject is in a state of physiological fatigue when the amount of human herpesvirus 6 or 7 in the sample obtained in (b) is greater than the average amount of human herpesvirus 6 or 7 in the sample obtained in (a).
19 . The method of claim 18 , wherein the physiological fatigue is due to an accumulation of physiological fatigue arising from everyday life.
20 . The method of claim 18 , wherein the amount of human herpesvirus 6 or 7 protein present in the sample is measured by an immunoassay method.
21 . A method of assessing the physiological fatigue level of a test subject comprising:
(a) preparing saliva samples from a test subject immediately after resting period; (b) preparing a saliva sample from the test subject of (a) at an arbitrary time point; (c) measuring the amount of human herpesvirus 6 or 7 in the samples obtained in (a) and (b) by measuring the amount of human herpesvirus 6 or 7 protein present in the samples; and (d) assessing that the physiological fatigue level of the test subject is high when the amount of human herpesvirus 6 or 7 in the sample obtained in (b) is greater than the average amount of human herpesvirus 6 or 7 in the sample obtained in (a).
22 . The method of claim 21 , wherein the physiological fatigue is due to an accumulation of physiological fatigue arising from everyday life.
23 . The method of claim 21 , wherein the amount of human herpesvirus 6 or 7 protein present in the sample is measured by an immunoassay method.
24 . A method of assessing the increase or decrease in the physiological fatigue level of a test subject comprising:
(a) preparing a base line saliva sample from a test subject; (b) preparing a saliva sample from a test subject of (a) at a time point different from when the base line sample of (a) is obtained; (c) measuring the amount of human herpesvirus 6 or 7 in the samples obtained in (a) and (b) by measuring the amount of human herpesvirus 6 or 7 protein present in the samples; and (d) assessing that the physiological fatigue level of the test subject at the time point, wherein if the amount of human herpesvirus 6 or 7 in the sample obtained in (b) is significantly greater than the amount of human herpesvirus 6 or 7 in the sample obtained in (a), then the physiological fatigue level is increased and wherein if the amount of human herpesvirus 6 or 7 in the sample obtained in (b) is significantly less than the amount of human herpesvirus 6 or 7 in the sample obtained in (a), then the physiological fatigue level is decreased.
25 . The method of claim 24 , wherein the physiological fatigue is due to an accumulation of physiological fatigue arising from everyday life.
26 . The method of claim 24 , wherein the amount of human herpesvirus 6 or 7 protein present in the sample is measured by an immunoassay method.
27 . A method of assessing the physiological fatigue level of a test subject comprising:
(a) preparing a saliva sample from a healthy adult immediately after resting period; (b) preparing a saliva sample from the test subject at an arbitrary time point; (c) measuring the amount of human herpesvirus 6 or 7 in the samples obtained in (a) and (b) by measuring the amount of human herpesvirus 6 or 7 protein present in the samples; and (d) assessing that the physiological fatigue level of the test subject is higher than the physiological fatigue level of the healthy adult immediately after resting period when the amount of human herpesvirus 6 or 7 in the sample obtained in (b) is significantly greater than the amount of human herpesvirus 6 or 7 in the sample obtained in (a).
28 . The method of claim 27 , wherein the physiological fatigue is due to an accumulation of physiological fatigue arising from everyday life.
29 . The method of claim 27 , wherein the amount of human herpesvirus 6 or 7 protein present in the sample is measured by an immunoassay method.
30 . A method of assessing the physiological fatigue level of a test subject comprising:
(a) preparing a saliva sample from a test subject immediately after resting period; (b) preparing a saliva sample from the test subject at an arbitrary time point; (c) measuring the amount of human herpesvirus 6 or 7 in the samples obtained in (a) and (b) by measuring the amount of human herpesvirus 6 or 7 protein present in the samples; and (d) assessing that the physiological fatigue level of the test subject at the time point when the sample obtained in (b) at an arbitrary time point is higher than the physiological fatigue level of the test subject immediately after resting period when the amount of human herpesvirus 6 or 7 in the sample obtained in (b) is significantly greater than the amount of human herpesvirus 6 or 7 in the sample obtained in (a).
31 . The method of claim 30 , wherein the physiological fatigue is due to an accumulation of physiological fatigue arising from everyday life.
32 . The method of claim 30 , wherein the amount of human herpesvirus 6 or 7 protein present in the sample is measured by an immunoassay method.Join the waitlist — get patent alerts
Track US2011020789A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.